Atorvastatin and trans-caryophyllene for the prevention of leukopenia in an experimental chemotherapy model in Wistar rats

Malignant neoplasia represents the second cause of disease-related mortality and, among all patients diagnosed with cancer, 70% will receive chemotherapy during the course of treatment. As a consequence, an increasing number of researchers have focused their attention on the search for more specific...

Full description

Saved in:
Bibliographic Details
Published in:Molecular and clinical oncology 2015-07, Vol.3 (4), p.825-828
Main Authors: CAMPOS, MARIA INES, VIEIRA, WELLINGTON DORIGHETO ANDRADE, CAMPOS, CELSO NEIVA, AARESTRUP, FERNANDO MONTEIRO, AARESTRUP, BEATRIZ JULIÃO VIEIRA
Format: Article
Language:English
Subjects:
Analgesics
Analysis
Animals
atorvastatin
Brazil
Cancer
Cancer therapies
Care and treatment
Chemotherapy
Diagnosis
Drug dosages
Experiments
Laboratories
Leucopenia
leukopenia
Lymphocytes
Mortality
Oncology
oral mucositis
Patients
Pentoxifylline
Permeability
Prevention
Rodents
Smooth muscle
Studies
trans-caryophyllene
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Malignant neoplasia represents the second cause of disease-related mortality and, among all patients diagnosed with cancer, 70% will receive chemotherapy during the course of treatment. As a consequence, an increasing number of researchers have focused their attention on the search for more specific anticancer therapies associated with fewer side effects. Leukopenia is an important adverse effect associated with chemotherapy. Secondary infection is very common among leukopenic patients, directly affecting the continuity of the chemotherapeutic treatment and leading to possible complications in tumor immune defense. Atorvastatin, a type of statin, is a known agent used to control hypercholesterolemia. Trans-caryophyllene, isolated from a resinous oil extracted from the copaiba tree, possesses anti-inflammatory and analgesic properties. The AIM of the present study was to evaluate, through a complete leukocyte count, the systemic immunomodulation potential of pentoxifylline (PTX), atorvastatin and trans-caryophyllene, as well as the possible prophylactic role of these drugs against secondary leukopenia, in an experimental chemotherapy model induced by 5-fluorouracil (5-FU) in wistar rats. A total of 32 male wistar rats were used, 24 of which were submitted to treatment with atorvastatin, PTX and trans-caryophyllene prior to the administration of chemotherapy. The Shapiro-Wilk test was used to verify normality and the Kruskal-Wallis test was used for negative data in the normality test. Among the drugs selected, atorvastatin exhibited the best preventive potential in regards to leukopenia secondary to experimental chemotherapy induced by 5-FU, in comparison to the group receiving saline solution, while PTX amplified such alterations in the leukograms of the animals in this trial.
ISSN:2049-9450
2049-9469
DOI:10.3892/mco.2015.544